Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Cancer Research and Clinical Oncology
Published in: Journal of Cancer Research and Clinical Oncology 6/2015

01-06-2015 | Letter to the Editor

Regarding Ening et al. Charlson comorbidity index: an additional prognostic parameter for preoperative glioblastoma patient stratification

Authors: Alba Fiorentino, Francesco Ricchetti, Rosario Mazzola, Sergio Fersino, Niccolò Giaj Levra, Filippo Alongi

Published in: Journal of Cancer Research and Clinical Oncology | Issue 6/2015

Login to get access

Excerpt

Dear Editor, …
Literature
Balducci M, Fiorentino A, De Bonis P, Chiesa S, Manfrida S, D’Agostino GR, Mantini G, Frascino V, Mattiucci GC, De Bari B, Mangiola A, Miccichè F, Gambacorta MA, Colicchio G, Morganti AG, Anile C, Valentini V (2012) Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies. Med Oncol 29(5):3478–3483CrossRefPubMed
Birim O, Kappetein AP, Bogers AJ (2005) Charlson comorbidity Index as a predictor of long term outcome after surgery for non small cell lung cancer. Eur J Cardiothoracic Surg 28:759–762CrossRef
Ening G, Osterheld F, Capper D, Schmieder K, Brenke C (2015) Charlson comorbidity Index: an additional prognostic parameter for preoperative glioblastoma patient stratification. J Cancer Res Clin Oncol. doi:10.​1007/​s00432-014-1907-9 PubMed
Fiorentino A, Caivano R, Chiumento C, Cozzolino M, Clemente S, Pedicini P, Fusco V (2012) Comorbidity assessment and adjuvant radiochemotherapy in elderly affected by glioblastoma. Med Oncol 29(5):3467–3471CrossRefPubMed
Fiorentino A, De Bonis P, Chiesa S, Balducci M, Fusco V (2013) Elderly patients with glioblastoma: the treatment challenge. Expert Rev Neurother 13(10):1099–1105CrossRefPubMed
LeCaer H, Fournel P, Jullian H, Chouaid C, Letreut J, Thomas P, Paillotin D, Perol M, Gimenez C, Vergnenegre A (2007) An open multicentric phase II trial of docetaxel-gemcitabine in Charlson score and performance status selected elderly patients with stage IIIB pleura/IV non-small-cell lung cancer: the GFPC 02–02a Study. Crit Rev Oncol Hematol 64:73–81CrossRefPubMed
Moro-Sibilot D, Aubert A, Diab S, Lantuejoul S, Fourneret P, Brambilla E, Brambilla C, Brichon PY (2005) Comorbidities and Charlson score in resected stage I non small cell lung cancer. Eur Respir J 26:3480–3486CrossRef
Metadata
Title
Regarding Ening et al. Charlson comorbidity index: an additional prognostic parameter for preoperative glioblastoma patient stratification
Authors
Alba Fiorentino
Francesco Ricchetti
Rosario Mazzola
Sergio Fersino
Niccolò Giaj Levra
Filippo Alongi
Publication date
01-06-2015
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 6/2015
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-015-1944-z

Other articles of this Issue 6/2015

Journal of Cancer Research and Clinical Oncology 6/2015 Go to the issue

Original Article – Cancer Research

In vitro effects and ex vivo binding of an EGFR-specific immunotoxin on rhabdomyosarcoma cells

Original Article – Cancer Research

BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation

Original Article – Clinical Oncology

Convergence with SEER database achieved by a breast cancer network: a longitudinal benchmark of 5-year relative survival

Original Article – Cancer Research

Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma

Original Article – Clinical Oncology

Differential diagnosis between metastatic and non-metastatic lymph nodes using DW-MRI: a meta-analysis of diagnostic accuracy studies

Review – Clinical Oncology

High dose versus conventional dose in external beam radiotherapy of prostate cancer: a meta-analysis of long-term follow-up
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits